Mice were subcutaneously inoculated with small numbers of virulent Cryptococcus neoformans and divided into groups. Numbers of viable yeasts at the site were estimated at weekly intervals for 5 weeks on the basis of cultures of minced tissue excised from sacrificed animals. Organisms multiplied at the site for at least 4 weeks and were still detectable after the 5th week, although in reduced numbers. Agglutinins appeared within a week, but these antibodies were not detectable during the 2nd through the 5th week. Cryptococcal polysaccharide began to appear in the sera at 3 weeks, persisting through the duration of 5 weeks. All animals appeared healthy, but a few sickened after many months and died of systemic cryptococcosis. All of these events were observed in many separate experiments. The immunizing capacity of a cutaneous lesion was tested by challenging some of the above animals with viable C. neoformans after various intervals of time, either subcutaneously at a site distant from that of the vaccination or intravenously. Although we were unable to demonstrate reduced multiplication of yeasts in the brains, lungs, and spleens of intravenously challenged animals, it was possible to show that multiplication was inhibited at the site of subcutaneous challenge. It was noted also that vaccinated animals lived longer after lethal intravenous challenge than did nonvaccinated animals. The latter protection was observed, however, only when challenge followed vaccination by 3 weeks or longer, and it was effective only against a relatively low challenge dose. Mice were protected against a higher dose if they had previously received killed cryptococci, alternating subcutaneous and intraperitoneal inoculations, one of which contained a microbial adjuvant. No protection was observed in animals that were subcutaneously vaccinated with inert materials such as chitin, latex spheres, or even cryptococcal cell walls themselves.
Systemic cryptococcosis is thought usually to be acquired by inhalation of infectious particles of Cryptococcus neoformans. It is unknown whether naturally acquired systemic disease is ever a consequence of subcutaneous implantation of viable organisms. Cutaneous cryptococcosis has been produced experimentally in a variety of animals, but usually these infections resolved spontaneously (4, 11, 15, 21, 22, 24) . The exceptions were attributed to inadvertent inoculation into deeper tissues (e.g., 15) .
It is also unknown whether a primary dernal lesion can have an immunizing effect upon a host. While our own investigations were in progress, Staib and Mishra (23) reported that the incidence of deaths among mice inoculated intramuscularly with a highly virulent isolate was significantly reduced when the animals previously had received an intramuscular injection of a different, avirulent isolate. Their results are not directly applicable, however, to events in naturally acquired infection, since primary intramuscular cryptococcosis has not been reported to our knowledge, and the chance of such occurrence would be minimal compared with implantation into the skin. Primary cutaneous lesions have been observed, albeit rarely (20) , and might even be a not infrequent although unrecognized occurrence, a presumption based upon the widespread distribution of this yeast in nature.
Experiments are described herein in which mice were subcutaneously inoculated with relatively small numbers of virulent C. neoformans and observed for morbidity and mortality. Companion animals so vaccinated were challenged by different routes after various time intervals to determine the immunizing capacity of an initial subcutaneous lesion. Morbidity and mortality, histological response, serologies, and tests for delayed hypersensitivity were compared between vaccinated and nonvaccinated animals. In parallel with some of these experiments, mice were inoculated with substances known or suspected to incite an inflammatory response, 446 on October 26, 2017 by guest http://iai.asm.org/ Downloaded from namely, chitin, latex particles, and cryptococcal cell walls. Other mice were subcutaneously and intraperitoneally vaccinated with killed cryptococci plus Bordetella pertussis adjuvant, a method first used by Abrahams in 1966 (1) . These animals also were challenged and observed for morbidity and mortality. It is intended that these studies provide a base for investigating host defense against this disease.
MATERIALS AND METHODS
Experimental animals and preparation of yeast inocula. C. neoformnans 145, originally isolated from human spinal fluid, was used throughout. Though heavily encapsulated on ordinary agar media, encapsulation was suppressed for these experiments by growing the organisms on Sabouraud agar or broth, each containing 16% glucose at pH 5.0 (5) . When viable cells were to be inoculated into animals, the cells were harvested from agar plates and suspended in sterile phosphate-buffered saline (PBS), and the concentration was adjusted such that a desired dose could be administered in a particular volume: 0.5 ml for inoculation of subcutaneous tissue at the back of the neck above the shoulder blades; 0.5 or 0.1 ml subcutaneously into a shaved right flank; or 0.5 ml intravenously into a lateral tail vein. The concentration of organisms in the inocula was confirmed by means of replicate pour plates prepared at the time of the inoculations.
Cell walls were prepared from organisms grown in broth for 72 h at 37°C, agitating at 150 gyrations/min, and then harvested by centrifugation at 10,000 x g for 30 min. Packed cells were washed three times by resuspension in PBS followed by centrifugation as before. After the final wash, the cells were suspended in a volume of PBS equal to that of the packed cells and killed by holding the suspension at 70°C for 1 h. Sterility was confirmed by streaking the suspension onto Sabouraud agar plates. Two drops of Tween 80 were added to 20-ml samples of the killed-cell suspension, and then each sample was agitated violently with 20 g of 0.25-to 0.30-mm sterile glass beads in a Braun homogenizer (Bronwill Scientific, Rochester, N.Y.). At 1-min intervals during homogenization, lactophenol cotton blue wet mounts were examined microscopically. Eighty to 90% of the cells had been broken by 10 min, at which time homogenization was discontinued and the glass beads were allowed to settle (about 5 min). The homogenate was removed and centrifuged at 1,000 x g for 15 min. This pellet was discarded, and the supernatant fluid was centrifuged at 12,000 x g for 30 min. After six washes, the final pellet was suspended in sterile PBS, the volume of which was nine times that of the pellet. Microscopic examination revealed that most, though not all, of the whole cells had been removed, leaving mostly ruptured cells and cell wall fragments. Despite the violence of the homogenization, however, all cell wall fragments seen had capsular material that adhered to the external portion of the wall as noted in India ink preparations.
Cryptococci used for killed-cell vaccines were collected from the "high-glucose" Sabouraud agar plates into sterile PBS containing 0.5% formalin and kept at ambient temperature for 2 (Fig. 1) .
A second experiment was done in which 53 mice were vaccinated subcutaneously and challenged intravenously along with 53 control mice precisely as before, except that the mice were challenged sooner, at 7 rather than 21 days. Twenty of each of the vaccinated and control groups were held for observation, and 33 of each were set aside to determine the in vivo fate of organisms. Of those held for observation, no protection was observed; during a period of 65 days, there was no difference in daily cumulative mortality (Fig. 2) .
Of those saved for investigating the fate of the organisms, three vaccinated and three control animals were sacrificed immediately after chal- that the small number of cells used for challenge in the second experiment had possibly been a factor in the wide variation in numbers of yeasts detected in the organs, reflecting a possibly greater variability of host-parasite relationships with a low challenge dose. Seventy-three mice were vaccinated. Twenty were challenged with 102, as previously, and 53 were challenged with 103 organisms. Of those receiving 103, 33 were sacrificed as before, their organs were cultured quantitatively, and the counts were compared with those of equal numbers of nonvaccinated 70 80 control animals. As in the previous experiment, the numbers of yeasts in the organs varied us vacci-greatly, and significant differences between con-Protection was confirmed in yet a fourth experiment in which vaccinated mice in two groups of 20 were challenged 21 curves were compared with those of nonvaccinated control mice concurrently infected. Protection was again observable, but only when the blemungs lower challenge dose was used (Fig. 4) (Fig. 5) . It was observed, however, that animals evidenced varying degrees of protection when challenge was delayed until 3 to 6 weeks after vaccination, and the strongest protection occurred in those animals challenged at the longest interval.
Immunizing effect of cutaneous infection (subcutaneous challenge). Sixty-five mice vaccinated with viable organisms subcutaneously in the neck and 65 nonvaccinated controls were challenged by inoculating 103 viable yeasts particles suspended in 0.5 ml of PBS into the subcutaneous tissue of the right flank 3 weeks after vaccination. Twenty of each group were held for observation, 30 of each were held for histological studies, and 15 from each were used to monitor survival of the challenge inoculum. For the latter, five mice from each group were sacrificed at 1, 3, and 7 days after challenge, the sera were saved, and the sites of subcutaneous challenge were excised and cultured. The organisms disappeared from the site in vaccinated mice; organisms were recovered after 1 and 3, but not 7, days, whereas control mice had viable yeasts at the challenge site at each observation. These data were confirmed in an e: which 50 vaccinated and 50 contrc challenged as before except that th( suspended in only 0.1 ml of PBS. and 14 days after challenge, the ino of 10 mice from each group was cultured. The numbers of colony-fi culturable from the flanks of the nc mice increased significantly throug servation period, whereas the numb cinated animals did not.
Of the 20 The animals set aside to study histological excised and reaction were sacrificed in groups of five vacciorming units nated and five nonvaccinated at 1 h and 1, 2, 3, )nvaccinated 5, and 7 days after challenge, and the sera were -hout the ob-saved. Histopathological sections of the tissues ers from vac-at the challenge sites revealed no apparent difference in response between the two groups of ccinated ani-mice; both showed a transient mononuclear ined for obser-filtrate that disappeared by the 5th day. Interr, 18 of each pretations of the histology were confirmed by ough 100 days Roger D. Baker. at 50 and 69
The sera obtained when mice were sacrificed -yptococcosis for the histological study or the yeast survival t. Until a few were tested for agglutinins and cryptococcal polysaccharide antigen. Agglutinins were demonstrable in the nonvaccinated control mice, but on only 1 day-the 7th after challenge-.
confirming the transient appearance of anticryptococcal antibodies that was noted previously. It was observed also that vaccinated mice had serum levels of cryptococcal polysaccharide at the time of challenge, although the polysaccharide could not be detected 2, 3, and 5 Five mice from each group were sacrificed, and the excised inoculation site was fixed in Formalin. Stained sections revealed large amounts of each inert material surrounded by an intense inflammatory response, characterized by infiltration of both polymorphonuclear leukocytes and mononuclear cells. The live-cell vaccine, on the other hand, apparently elicited no inflammatory response; however, cryptococci could be seen in only one tissue specimen out of five.
The surviving animals of the original four groups as well as 20 nonvaccinated control mice were challenged with 102 viable units of C. neoformans and observed 50 days for morbidity and mortality. Animals previously inoculated with chitin, latex particles, or cell walls died at the same rate as control mice. Mice vaccinated with live cells, however, died at a slower rate, although early death occurred at about the same time as did the first deaths in the groups in which protection was not evident.
Tests for delayed hypersensitivity. At several points during most of the previously described experiments, tests for delayed hypersensitivity were performed. Mice that had been given a single cutaneous inoculation of live cells were tested 1, 17, and 24 days after infection; those that had been vaccinated with live cells and intravenously challenged with live cells were tested 7 and 21 days after challenge; and those that had been vaccinated with killed cryptococci and microbial adjuvant were tested 8 and 21 days after challenge. Responses to the two skin test antigens were consistently negative; average thickness of the ears or footpads in both experimental and normal mice were comparable in size and always had returned to the original thickness by 24 h.
DISCUSSION
The initial purpose of these experiments was to investigate mechanisms of host defense in cryptococcosis. That there is a good defense seems obvious inasmuch as the agent is widespread in nature, and therefore most individuals must be frequently exposed even though relatively few develop the disease. Several studies have failed to demonstrate protection of animals after immunization (S. Marcus and R. F. Rambo, Proc. Soc. Am. Bacteriol. 8:92, 1955; 7, 10) . In vitro experiments suggest an effective nonimmune defense by phagocytosis (16) , but the net effectiveness in terms of resistance to disease within an intact host has not been demonstrated. Neither has it been possible to show stimulation of a protective immunological defense engendered by infection, although it seems plausible that the immune system is involved, inasmuch We decided to first investigate the consequence of a subcutaneous infection, reasoning that the likelihood of inducing a protective response, be it immunological or not, would be as a result of an actual infection. Also, such a system would easily allow use of only a single isolate for both vaccination and challenge, as opposed to vaccination with an avirulent isolate and challenge with another, thus avoiding possible complication by heterogenous antigenic subtypes. Additionally, it was considered that subcutaneous infection might not be infrequent as a natural event in epidemiology of human disease.
This approach required knowledge of the pathogenesis of cutaneous infection. Accordingly, mice were subcutaneously inoculated with viable C. neoformans, and, as anticipated, subcutaneous cryptococcosis was a benign experience for the great majority of the animals. Nevertheless, such lesions did not quickly resolve. Rather, the yeast inoculum survived and multiplied for at least 4 weeks, although elimination of viable organisms did begin during the 5th week. Animals almost always remained free, however, of grossly discernible lesions such as nodules or ulcers; there were only three instances during this entire study when palpable lesions appeared at the site of a subcutaneous infection, and these were histologically granulomatous. It was additionally apparent that multiplication of organisms was usually checked at some point, since aged mice almost always appeared healthy and had neither abscesses nor any gross evidence whatsoever of infection. In a few instances, however, some of these animals died of systemic cryptococcosis after months of appearing entirely normal. This low incidence of mortality differs from the observations of Bergman, who in 1961 found that large numbers of viable cryptococci inoculated into the dorsum of a hind foot resulted in death in a majority of his mice (3). Our results are compatible, however, with most studies in that deaths were few after subcutaneous inoculation (e.g., 11, 21, 22) . Although it seems reasonable to assume that subcutaneous inoculation is only infrequently followed by hematogenous or lymphatic spread, as was evident by the rarity of deaths observed by us and others, and by analogy with other fungus diseases (e.g., coccidioidomycosis and blastomycosis; 25), a recent study by Song (22) (6) . An alternate explanation for the infectiousness of C. neoformans can be offered based upon the recent report of Kwon-Chung (14) , who has described the sexual spore of the perfect stage of this organism, the basidiospore, which by virtue of its small size (1.8 to 2.5 ,um) could more easily make its way deep into the lungs, but the distribution of this form in nature cannot be speculated upon at this time. If the basidiospore should prove to be the infectious unit and is sparsely distributed in nature, then infection may be infrequent, despite preliminary skin test data suggesting that approximately a third of human beings are positive to cryptococci (17) .
A final aspect of our study may have bearing upon the consensus that heavily encapsulated cryptococci are less antigenic (i.e., stimulate lower antibody levels) than are cryptococci that are small capsuled or nonencapsulated or from which the capsule has been chemically removed (10, 19) . It has been our experience, as well as that of others (e.g., 12), that humans with cryptococcosis have polysaccharide rather than antibody in their serum, and that in human disease the organism usually is heavily encapsulated. It is probable that freed polysaccharide, sloughed from heavily encapsulated cells, reacts with and masks the presence of antibody. We invariably observed polysaccharide in the serum of mice after subcutaneous inoculation of viable nonencapsulated cryptococci, but shortly after admin-presumption is made-and admittedly the presumption is highly speculative-that the temporary disappearance of polysaccharide was due to binding by antibody, it can be concluded that a booster effect occurred as a result of the second inoculation. Irrespective of the mechanism, there is an important counterpart in human disease. From a diagnostic standpoint, it is important to emphasize that whereas antibody often is absent, polysaccharide often is present and is easily detected by a simple laboratory test using commercially available reagents.
